biperiden has been researched along with Blepharoptosis in 1 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Blepharoptosis: Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oka, M | 1 |
| Yamada, K | 1 |
| Kamei, C | 1 |
| Yoshida, K | 1 |
| Shimizu, M | 1 |
1 other study available for biperiden and Blepharoptosis
| Article | Year |
|---|---|
Differential antagonism of antiavoidance, cataleptic and ptotic effects of neuroleptics by biperiden.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Biperiden; Blepharoptosis; Catalepsy | 1979 |